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Abstract
Background: Unfavorable left ventricular (LV) remodelling may be associated with adverse outcomes after
Tetralogy of Fallot (TOF) repair. We sought to assess T1 cardiovascular magnetic resonance (CMR) markers of
diffuse LV myocardial fibrosis in children after TOF repair, and associated factors.
Methods: In this prospective, cross-sectional study, native (=non-contrast) T1 times and extracellular volume
fraction (ECV) were quantified in the LV myocardium using CMR. Results were related to ventricular volumes
and function, degree of pulmonary regurgitation, as well as surgical characteristics, and exercise capacity.
Results: There was no difference in native T1 times or ECV between 31 TOF patients (age at CMR 13.9 ± 2.4 years,
19 male) and 15 controls (age at CMR 13.4 ± 2.6 years, 7 male). Female TOF patients had higher ECVs than males
(25.2 ± 2.9 % versus 22.7 ± 3.3 %, p < 0.05). In the patient group, higher native T1 and ECV correlated with higher
Z-Scores of right and left ventricular end-diastolic volumes, but not with reduced left and right ventricular ejection
fraction or higher pulmonary regurgitation fraction. Longer cardiopulmonary bypass and aortic cross clamp times
at surgery correlated with increased native T1 times and ECVs (r = 0.48, p < 0.05 and r = 0.65, p < 0.01, respectively).
Maximum workload (percent of predicted for normal) correlated inversely with ECV (r = -0.62, p < 0.05). Higher
native T1 times correlated with worse LV longitudinal (r = 0.50, p < 0.05) and mid short axis circumferential strain
(r = 0.38, p < 0.05).
Conclusions: As compared to controls, TOF patients did not express higher markers of diffuse fibrosis. Longer
cardiopulmonary bypass and aortic cross clamp times at surgery as well as biventricular enlargement and reduced
exercise tolerance are associated with markers of diffuse myocardial fibrosis after TOF repair. Female patients have
higher markers of diffuse myocardial fibrosis than males.
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Background
While the vast majority of patients after repair for Tet-
ralogy of Fallot (TOF) survive well into their adult years
[1], there is progressive decline not only in right ven-
tricular (RV), but also in left ventricular (LV) function
[2]. Even though TOF is primarily a ‘right-sided’ heart
disease, LV dysfunction is well recognized and predicts
adverse outcomes after TOF repair [3, 4]. Myocardial
fibrosis has been associated with LV dysfunction in a
number of cardiac conditions, including adult patients
with TOF [5, 6]. It is conceivable that myocardial injury
triggered by cardiopulmonary bypass and ischemia-
reperfusion sets in motion a profibrotic cascade.
Longitudinal relaxation or T1 times and extracellular
volume fraction (ECV), measured with cardiovascular
magnetic resonance (CMR), have been established as
non-invasive markers of diffuse myocardial fibrosis [7].
Both have been validated against histology in the LV of
adult patients with different types of heart diseases [8].
However, only very preliminary data exist on the extent
and clinical importance of diffuse LV myocardial fibrosis
in pediatric TOF patients [6].
The aim of this study was to measure native T1 times
and ECV in children after TOF repair, and to under-
stand their potential origin and clinical significance.
Methods
The cohort in this prospective, single-center study in-
cluded patients with repaired TOF who underwent a
non-sedated clinical contrast-enhanced CMR between
March 2014 and January 2015. Patients with 'TOF type'
double outlet right ventricle were included. Patients with
pulmonary atresia and no major aortopulmonary collat-
eral arteries were also included. Patients with pulmonary
valve replacement following the initial complete repair
and before CMR were excluded.
Immediately prior to the CMR, blood was drawn to
measure the hematocrit. Patients’ records were reviewed
for demographic, clinical and surgical details. QRS dur-
ation was determined if an ECG was available within
6 months of the CMR. Echocardiograms performed
within 6 months from CMR were reviewed for degree of
tricuspid valve insufficiency, estimated right ventricular
systolic pressure as assessed via the tricuspid regurgita-
tion jet, tricuspid annular plane systolic excursion
(TAPSE) and the peak gradient across the right ventricu-
lar outflow tract. Exercise test results were reviewed if
performed within 6 months from CMR.
Patients who underwent CMR for screening purposes
for palpitations, non-specific chest pain, or family history
of arrhythmogenic right ventricular cardiomyopathy




All CMR examinations were performed on a 1.5 Tesla
scanner (Magnetom Avanto, Siemens AG Healthcare
Sector, Erlangen, Germany) using a phased-array
multi-channel surface receiver coil. A modified Look-
Locker inversion recovery sequence (MOLLI) [9] was
used to measure T1 times of myocardium and blood. The
sequence consisted of two inversion-recovery prepared
ECG synchronized Look-Locker experiments with inver-
sion pulses at 120 ms and 200 ms after the R-spike, re-
spectively, as well as 5 and 3 single-shot images after these
inversion pulses. The pause (measured in beats) be-
tween the two Look-Locker experiments was adjusted
according to the patients’ heart rate: three heart beats
up to a heart rate of 80 bpm, four heart beats for heart
rates > 80 and < 100 bpm, and five heart beats for pa-
tients with a heart rate of 100 bpm and higher. Other
sequence parameters were as follows: Repetition and
echo times 2.7 ms and 1.1 ms respectively; in-plane
resolution 2.0x1.3 mm, slice-thickness 8 mm; flip
angle 35°. Images were acquired in diastole in mid-
ventricular and basal short axis (SA) planes before
and 15 min after the intravenous administration of
0.1 mmol/kg gadobenate dimeglumine (Multihance®,
Bracco Imaging, Montreal, Quebec, Canada). Breath-
holds were used in cooperative patients; all other pa-
tients were scanned during free breathing. A cine 4-
chamber slice and a stack of multiphase SA slices
were acquired in the steady state free precession tech-
nique to measure LV and RV volumes, as described
previously [10]. Blood flow volumes were measured in
the main, right and left pulmonary arteries using
phase contrast flow velocity mapping in the usual
clinical fashion [11].
The presence of LV late gadolinium enhancement
(LGE) was determined qualitatively on standard long-
axis (4-chamber, 2-chamber and 3-chamber) and SA
images using phase-sensitive inversion-recovery acquisi-
tions ≥ 10 min after administration of the contrast agent
(same injection as described above).
Image processing
Using the 8 raw images of the MOLLI sequence, na-
tive and post-contrast T1 times were measured by an
experienced observer (ER), using commercially avail-
able software (CVI42, Circle Cardiovascular Imaging,
Calgary, AB, Canada). Regions of interest were drawn
in mid and basal SA in the interventricular septum,
the LV free wall, the entire LV myocardium and in
the LV blood pool, avoiding papillary muscles. If ne-
cessary, contours were adjusted in each phase. Myo-
cardial contours comprised the central 2/3 of the
myocardium, in order to avoid possible signal averaging
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with signal from blood or pericardial fat. For assessment
of intra- and interobserver variability, all contours were
redrawn by the primary as well as by a second observer in
15 randomly selected TOF patients.
ECV was calculated using the following formula [12]:
ECV ¼ 1−hematocritð Þ 
1









RV and LV volumes were measured from the stack of SA
cine images in systole and diastole with calculation of ejec-
tion fraction. LV muscle mass was measured in diastole
(Medis Q-Mass 7.6, Leiden, The Netherlands). RV muscle
mass was measured in the patient group in diastole. Re-
sults were indexed to body surface area, and Z-scores for
ventricular volumes and ejection fractions were calculated
using published normative data [13].
Cardiomechanics were measured using steady state
free precession cine imaging and CMR feature tracking
with commercially available software (Image Arena Ver-
sion 4.6, TomTec Imaging Systems, Unterschleissheim,
Germany). The following parameters were assessed: Peak
LV longitudinal strain and strain rate from 4-chamber
view; circumferential strain and strain rate at the LV mid
and basal SA levels, as well as LV torsion, calculated
from rotation and ventricular dimensions as described
elsewhere [14]. Pulmonary artery flow was quantified
using Q-Flow 5.6 (Medis, Leiden, The Netherlands).
Statistical analysis
Data is described as means with standard deviations
or medians with interquartile ranges (IQR) or fre-
quencies as appropriate. Comparisons between groups
(TOF patients and controls) and TOF subgroups were
performed using Fisher’s exact test for categorical var-
iables, and Student’s t-test for continuous variables,
assuming unequal variance between samples (Sat-
terthwaite methods). Associations of age, gender,
heart rate, BSA, hematocrit and QRS-duration with
T1 mapping results in TOF patients and controls
were modelled in linear regression models (maximum
likelihood method for parameter estimation). Pearson
correlations were computed to assess associations be-
tween continuous variables. Variables with associa-
tions with fibrosis markers were entered into
multivariable regression models for native T1 times
and ECV. Intra- and interobserver variability for na-
tive T1 times and ECV were assessed using the
Bland-Altman method. All statistical analyses were
performed using SAS Version 9.3 (SAS statistical
software, Cary NC). P values < 0.05 were considered
significant.
Results
Thirty-six patients after TOF repair met the inclusion
criteria. Five patients were excluded from the analysis:
Two patients had undergone late repair at the age of
8 years and were regarded as non-representative of the
current surgical era; one patient had a VSD patch leak
with a residual shunt of Qp:Qs 1:5. T1 mapping images
were non-diagnostic in two patients.
Characteristics of the remaining 31 patients in com-
parison to 15 controls and surgical information of the
patients are summarized in Table 1.
Ventricular volumes and function
Results of CMR and echocardiography are shown in
Table 2. As expected, the RVs of patients were enlarged as
compared to controls, and biventricular ejection fraction
was reduced. Male TOF patients had larger ventricular vol-
umes as compared to females (indexed right and left ven-
tricular enddiastolic and endsystolic volumes: LVEDVi 95
± 12 versus 85 ± 9 ml/m2; LVESVi 44 ± 8 versus 37 ± 7 ml/
m2; RVEDVi 159 ± 44 versus 129 ± 23 ml/m2; RVESVi
82 ± 26 ml/m2 versus 64 ± 14 ml/m2, all p < 0.05) and
a higher RV muscle mass (44 ± 9 versus 32 ± 3 g/m2,







Age at CMR [years] 13.9 ± 2.4 13.4 ± 2.6 0.54
Gender [male; n (%)] 19 (61 %) 7 (44 %) 0.53
BSA [m2] 1.47 ± 0.27 1.55 ± 0.30 0.41
Heart rate [bpm] 73 ± 11 76 ± 11 0.31
Hematocrit 0.44 ± 0.04 0.42 ± 0.04 0.16
QRS-duration [ms]a 123 ± 24 87 ± 8 <0.001
Surgical information
Patient age at repair [months] 6.3 (3.0–10.7) n.a. n.a.
Time since repair at CMR [years] 13.2 ± 2.2 n.a. n.a.
TOF type [n (%)] n.a. n.a.
TOF
TOF with pulmonary atresia
25 (81 %)
6 (19 %)






Bypass time [minutes]c 136 ± 48 n.a. n.a.
Cross clamp time [minutes]c 67 ± 19 n.a. n.a.
Data are given as mean ± standard deviation, median (and interquartile range),
or frequencies, as appropriate
Abbreviations: BSA body surface area, CMR cardiovascular magnetic resonance,
n.a. not applicable, TOF Tetralogy of Fallot
aQRS-duration from ECG was available in 26 patients and 11 controls
bType of repair unknown in one patient. One patient had a palliation prior to
corrective surgery
cCardiopulmonary bypass and aortic cross clamp times from 23 patients
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p < 0.001). There were no gender differences in ejection
fraction of both ventricles and LV muscle mass in the
TOF group. Female patients had been slightly younger
at the time of repair (median age 3.8 (IQR 0.7–6.7) ver-
sus 7.4 (IQR 5.4–12.6 months, p < 0.05).
In TOF patients RVEDVi correlated with LVEDVi
(r = 0.52, p < 0.005). There was no correlation between
RV and LV ejection fractions or between their respective
Z-scores.
Mid SA circumferential strain was weaker in the
patient group as compared to controls (−21.5 ± 3.8 %
versus −24.1 ± 3.3 %, p < 0.05). Other cardiomechanical
values (basal and mid circumferential strain rate and
basal mid circumferential strain) did not show signifi-
cant differences.
Echocardiographic data was available in 29 patients
within 6 months of CMR (Table 2). The median time
difference between echocardiography and CMR was
20 days (IQR 0-50 days).
Cardiopulmonary exercise test and QRS duration
QRS durations in TOF patients and controls are pro-
vided in Table 1. Exercise test results were available in
15 patients within 6 months from CMR. The median
time difference of both investigations was 39 days
(IQR 19–60 days). Expressed as percent of predicted
for normal, maximal workload was 96 ± 12 % and
oxygen uptake at anaerobic threshold was 93 ± 30 %.
Males (n = 9) had a higher percentage of predicted oxy-
gen uptake at anaerobic threshold than females (110 ±
23 % versus 69 ± 20 %, p < 0.05).
Native T1 and ECV
Native T1 times and ECV are listed in Table 3. There
were no significant differences between patients and
controls for all regions analysed within the LV. In TOF
patients, septal values were higher as compared to the
free wall in mid and basal SA (native T1 times basal SA
989 ± 43 ms versus 963 ± 52 ms, p < 0.05; ECV mid SA
Table 2 Results from CMR and echocardiography
Patients (n = 31) Controls (n = 15) p
CMR
Ventricular volumetry and pulmonary flow
RV enddiastolic volume [ml/m2] 148 ± 40 93 ± 13 <0.001
RV endsystolic volume [ml/m2] 75 ± 23 43 ± 8 <0.001
RV muscle mass [g/m2] 39.4 ± 9.4 n.a. n.a.
RV ejection fraction [%] 50 ± 5 53 ± 3 <0.05
LV enddiastolic volume [ml/m2] 91 ± 12 89 ± 11 0.50
LV endsystolic volume [ml/m2] 41 ± 8 36 ± 6 <0.05
LV muscle mass [g/m2] 46 ± 7 49 ± 9 0.29
LV ejection fraction [%] 55 ± 6 59 ± 4 <0.01
Pulmonary regurgitation [%] 33 ± 16 n.a. n.a.
Z-Scores
RV enddiastolic volume 3.42 (1.52–5.29) −0.11 (−1.17–0.68) <0.001
RV endsystolic volume 3.65 (1.52–4.51) −0.05 (−0.33–0.98) <0.001
RV ejection fraction −1.52 (−2.23– −0.69) −1.04 (−1.29– −0.39) <0.05
LV enddiastolic volume 0.62 ( −0.10–1.36) 0.41 (−0.55–1.59) 0.60
LV endsystolic volume 1.57 (−0.75–2.30) 1.08 (−0.31–1.65) <0.05
LV muscle mass −1.89 (−2.90– −0.94) −0.96 (−2.43–0.36) 0.24
LV ejection fraction −1.29 (−2.51– −0.80) −0.32 (−1.41–0.41) <0.01
Echocardiography
RVSP [mmHg], n = 19 44 ± 15 n.a. n.a.
RVOT-gradient [mmHg], n = 29 32 ± 18 n.a. n.a.
TAPSE [mm], n = 19 16.5 ± 3.5 n.a. n.a.





Data are given as mean ± standard deviation, median (and interquartile range), or frequencies, as appropriate
Abbreviations: LV left ventricle, PT pulmonary trunk, RV right ventricle, RVOT right ventricular outflow tract, RVSP right ventricular systolic pressure, TAPSE tricuspid
annular plane systolic excursion
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24.3 ± 3.7 % versus 22.3 ± 3.8 %, p < 0.05). These differ-
ences were not present in the control group.
Female TOF patients had higher values as compared
to male TOF patients for native T1 in the basal interven-
tricular septum (1009 ± 41 versus 976 ± 40 ms, p < 0.05)
and for ECV in all parts analysed (e.g., mid SA entire LV
25.2 ± 2.9 % versus 22.7 ± 3.3 %, p < 0.05). No patient
had LV LGE.
Intra- and interobserver variability
Mean bias, coefficient of variation, standard deviation
and limits of agreement of inter- and intraobserver vari-
ability for native T1 times and ECV in mid SA for the
entire LV are shown in Fig. 1.
Associations between T1 and ECV and demographic and
surgical factors
Age at surgery correlated inversely with native T1 and
ECV in the IVS (r = −0.504, p < 0.005 and r = −0.447,
p < 0.05, respectively) and entire LV (r = −0.420, p < 0.02
Table 3 ECV and native T1 results
Patients n Controls n p
Native T1 (ms)
Entire left ventricle mid 974 ± 37 29 986 ± 29 15 0.26
base 982 ± 37 31 998 ± 25 15 0.10
Interventricular septum mid 990 ± 49 31 1000 ± 39 15 0.44
base 989 ± 43 31 999 ± 28 15 0.34
Left ventricular free wall mid 970 ± 50 31 989 ± 46 15 0.20
base 963 ± 52 30 983 ± 30 15 0.11
Extracellular volume (%)
Entire left ventricle mid 23.6 ± 3.3 28 23.4 ± 3.0 14 0.84
base 24.0 ± 3.2 28 22.9 ± 2.6 13 0.25
Interventricular septum mid 24.3 ± 3.7 30 22.8 ± 2.7 14 0.13
base 23.7 ± 3.3 29 23.1 ± 2.8 13 0.57
Left ventricular free wall mid 22.3 ± 3.8 30 23.1 ± 2.7 14 0.43
base 22.3 ± 3.9 27 21.5 ± 2.4 13 0.45
Data are given as mean ± standard deviation. The varying numbers n of available
values for the different measurements is attributed to image quality, i.e., image
quality of some native or post contrast T1 maps was reduced in parts
Fig. 1 Inter- and intraobserver variabilities of native T1 and ECV. Inter- and intraobserver variabilities of native T1 and ECV measured in the entire
LV in mid short axis. Abbreviations: COV = coefficient of variation; ECV = extracellular volume; LV = left ventricle; SD = standard deviation
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and r = −0.468, p < 0.01, respectively) at the base. Longer
cardiopulmonary bypass time correlated with elevated
native T1 time of the IVS (r = 0.48, p < 0.05), and with
higher ECV of the entire LV (r = 0.46, p < 0.05) and IVS
(r = 0.48, p < 0.05), all at the mid SA level. Longer aortic
cross clamp time correlated with higher native T1 of the
LV free wall in mid SA (r = 0.65, p < 0.01). In a multivari-
able analysis of age at surgery, cardiopulmonary bypass
and aortic cross clamp times, longer bypass and cross
clamp times were independently associated with ele-
vated native T1 and ECV (in the regions described
above). Patients who had undergone either a valve spar-
ing or valved conduit repair had lower fibrosis markers
than patients who had a transannular patch repair (na-
tive T1 entire LV mid SA 960 ± 28 versus 991 ± 40 ms,
p < 0.05; ECV entire LV basal SA 22.6 ± 2.7 % versus
26.0 ± 3.0 %, p < 0.01). Expectedly, pulmonary regurgi-
tant volume was higher in the transannular patch group
(2.53 ± 1.30 versus 1.48 ± 1.14 L/min/m2, p < 0.05).
Maximal workload (percent of predicted for normal)
correlated inversely with ECV of the entire LV in basal
SA (r = −0.62, p < 0.05) and ECV of the basal LV free
wall (r = −0.68, p < 0.05).
Associations between T1 and ECV and ventricular
function and exercise tolerance
Indexed ventricular volumes did not correlate with T1
mapping results. However, higher Z-scores of LVEDV,
RVEDV and RVESV correlated with higher ECV in mid
SA in all regions analysed (e.g., for entire LV r = 0.39,
p < 0.05, r = 0.46, p < 0.01, and r = 0.43, p < 0.05, re-
spectively). There were no correlations of T1 mapping
results with LV or RV ejection fraction or pulmonary
regurgitation. Neither T1 times nor ECV correlated
with RV systolic pressure or TAPSE by echocardiog-
raphy. Worse (i.e., less negative) left ventricular 4-
chamber longitudinal strain correlated with higher na-
tive T1 times (entire LV mid SA r = 0.50, p < 0.05; IVS
mid SA r = 0.55, p < 0.05; IVS basal SA r = 0.50, p <
0.05). At the midventricular SA level, there was a weak
correlation of higher native T1 times of the LV free
wall and worse circumferential strain (r = 0.38, p <
0.05). There were no further correlations between T1
mapping (T1 and ECV) and myocardial strain, strain
rate or torsion.
Discussion
Adult survivors after TOF repair have evidence of increased
LV ECV, quantified by CMR T1 mapping [5, 15, 16]. In an
earlier pilot study, we found preliminary evidence for a
higher LV fibrosis burden in pediatric TOF patients [6]. To
the best of our knowledge, the current study is the first pro-
spective investigation on the degree, potential etiology, and
clinical significance of CMR markers of myocardial
fibrosis in young patients after TOF repair. The princi-
pal novel findings of this study are:
I. On average, children and adolescents do not
express CMR markers of increased amounts of
LV myocardial fibrosis.
II. Higher ECV is associated with larger LV and RV
volumes.
III.Longer cardiopulmonary bypass and aortic cross
clamp times and younger age at primary surgical
repair are associated with higher native T1 times
and ECV.
IV.The transannular patch approach is associated
with higher markers of fibrosis than valve sparing
techniques and valved RV to pulmonary artery
conduits.
V. Higher markers of diffuse fibrosis are associated
with myocardial dysfunction and reduced
cardiopulmonary exercise tolerance.
Although primarily a ‘right heart’ condition, LV dys-
function is not uncommon in TOF and a risk factor for
adverse outcomes [3, 4]. The interactions between RV
and LV physiology are well recognized, but the patho-
physiology of them is incompletely understood: Un-
favourable RV hemodynamics and septal physiology
have been proposed as mediators of RV/LV ‘cross-talk’
[17, 18]. In the present study LVEDV correlated with
RVEDV. The association of LV ECV not only with LV
but also with RV volume make it tempting to speculate
that ventricular interaction also exists on a tissue level.
In fact, Friedberg et al. recently showed experimentally
that abnormal RV loading leads not only to right, but
also to left ventricular fibrosis, probably via the trans-
forming growth factor pathway [19]. Native T1 times
and ECV were higher in the IVS than in the LV free
wall in patients, but not in controls. Although specu-
lative, the higher fibrosis markers in the IVS could
mean that ventriculoventricular interactions affect
mainly the part of the myocardium that is directly ad-
jacent to the RV with which it shares fibres. Studies
that include reliable ECV measurements in the RV
will be necessary to understand regional variations of
fibrotic remodeling.
Our previous pilot study suggested increased LV fibro-
sis in children with repaired TOF [6]. However, those
conclusions rested on a small number of patients who
had post-contrast T1 mapping only, an approach which
is now considered inferior to ECV and native T1 as
markers of fibrosis [7]. In the current larger prospective
study there were no differences of native T1 times and
ECV between patients and controls. This is in agreement
with studies in adults with ischemic and valvar heart
disease which consistently report significant overlap of
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health and disease [20]. In contrast to our study Broberg
et al. found higher ECVs in adult TOF patients than in
controls [5, 15]. Importantly, their patients were, on
average, 20 years older than ours. As a consequence,
Broberg’s patients had had more time for adverse LV
remodelling and adverse clinical outcome to occur; even
so, 37 out of their 52 TOF patients [15] had ECVs in the
normal range and the TOF subgroup had the lowest
average ECV of all congenital heart disease patients [5].
The larger RVs and LVs in Broberg’s adult TOF patients
as compared to our pediatric patients are further hall-
marks of remodeling which, in our study, are associated
with CMR markers of fibrosis. In addition, the patients
in Broberg’s study may represent a different ‘surgical
era’: Our results support the influence of surgical strat-
egy on late myocardial remodelling: Firstly, patients after
transannular patch repair, the strategy which prevailed
during the surgical era in Broberg’s study, had higher
ECV in our study than patients who received a valved
RV outflow tract. The reasons for this difference remain
speculative. Whether it is the RV volume loading which
is more severe in patients after transannular patch or
whether the strategy of transannular patch is a surrogate
for more severe preoperative outflow tract obstruction is
unclear [21]. Secondly, surgical procedural factors like
longer cardiopulmonary bypass and cross clamp times
were related to increased markers of myocardial fibro-
sis. An association of these parameters with fibrotic
myocardial remodelling more than a decade after
repair of congenital heart disease has not previously
been appreciated, although we know from endomyo-
cardial biopsies in patients after heart transplantation
that longer graft ischemia time is associated with more
ventricular scarring [22]. The results from this study
underscore the importance of optimal cardioprotec-
tion and of minimizing the duration of cardiopulmo-
nary bypass and aortic cross clamp times. The
pathophysiolgy of fibrotic remodelling in congenital
heart disease, including TOF, is largely unknown. Be-
sides myocardial injury from surgery genetic upregula-
tion of collagen synthesis, chronic hypoxia, and
hemodynamic disturbances have all been named as
possible promoters of fibrosis [21].
Recently, a study in adults with repaired TOF found
ECV to be associated with arrhythmia [16]. An explor-
ation of the pediatric TOF cohort with CMRs at our in-
stitution revealed no deaths and a very low incidence of
ventricular tachyarrhythmia (unpublished data) which
means that a risk-prediction analysis with T1 relaxome-
try in young patients has to rely on surrogate parameters
of adverse clinical status and outcomes, such as exercise
tolerance. Indeed, ECV correlated with lower maximum
workload. Girls after TOF repair expressed higher
markers of fibrosis than boys, which has been shown in
adult TOF patients [15, 16]. It is interesting to note that
girls also had larger ventricles, lower ejection fractions
and weaker exercise tolerance, corroborating previous
reports [23, 24]. Together, these data suggest a more
rapid deterioration of cardiovascular health in female
TOF patients.
Whether myocardial fibrosis causes impaired myocar-
dial contractility remains to be clarified. In the patients
studied here CMR markers of fibrosis were not related
to LV ejection fraction, but higher ECV and native T1
were associated with decreased LV myocardial contract-
ility, as evidenced by lower longitudinal and circumfer-
ential strain. These associations suggest that fibrotic
remodelling does, indeed, translate into loss of myocar-
dial function, even though the health of LVs of juvenile
TOF patients is relatively preserved.
Limitations
T1 and ECV in different regions of the heart correlated
with the various clinical parameters, likely due to the
limited sample size, and the region with the highest
diagnostic yield remains to be identified. Likewise, it is
unclear whether ECV offers a diagnostic advantage over
non-contrast native T1. It would be preferred to be able
to avoid the use of gadolinium in light of concerns re-
garding possible gadolinium deposition in the brain [25]
and nephrogenic systemic fibrosis [26]. Shortening the
inversion times within the MOLLI sequence is advisable
for post-contrast T1 times, taking into account the
shorter T1 recovery kinetics [27]. Although a motion-
correction algorithm was employed and the eight
MOLLI raw images were reviewed for misregistration,
this approach remains inferior to acquisitions during
breathholding [28]. Whether or not ECV can be mea-
sured reliably in the RV is under debate [5]. Plymen
and colleagues reported that even in systemic RVs of
adult patients a reliable assessment of ECV was not
possible [29]. Chen et al., in their study of adult TOF
patients, were able to measure RV ECV with acceptable
reproducibility [16]. In our experience the quantifica-
tion of post-contrast T1 in the RV of children without
myocardial hypertrophy often fails. We, therefore, did
not include RV ECV in our analysis.
Conclusions
On average, children and adolescents after TOF repair
do not express increased native T1 or ECV. Nonetheless,
elevated CMR markers of LV fibrosis are associated with
biventricular enlargement and LV myocardial dysfunc-
tion. Longer cardiopulmonary bypass and aortic cross
clamp times appear to plant the seed for chronic fibrotic
LV remodeling. Longitudinal studies are needed to in-
form us about the contribution of CMR T1 mapping to
the prediction of outcomes in TOF patients.
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